The Frasier syndrome Market size is expected to reach US$ 200.5 Mn by 2030, from US$ 141.2 Mn in 2023, at a CAGR of 5.1% during the forecast period. Frasier syndrome is a rare genetic disorder characterized by male-to-female sex reversal along with developmental defects of the kidneys and reproductive organs. It is caused by mutations in the WT1 gene. Frasier syndrome diagnosis involves genetic testing and biochemical testing to analyze the level of protein in the body. The increasing prevalence of the disease and growing awareness are the key factors driving market growth.
The Frasier syndrome market is segmented by test type, end user, and region. By test type, the market is segmented into genetic testing, biochemical testing, and others. The genetic testing segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the accuracy and specificity of genetic tests. Genetic testing helps in the early diagnosis of the disease.
Frasier Syndrome Market Trends:
Frasier Syndrome Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients